How High Tide became the leading cannabis retailer in Canada 👇🏻🧵 $HITI
Here's the story of how High Tide evolved from day one until now.
The beginning 🌱
Raj Grover, the founder and CEO who owns ~9% of the company and has never sold a single share, comes from an entrepreneurial family and had already experienced success with several smaller businesses before establishing $HITI. During a business trip to India in search of opportunities in fashion accessories or body jewelry, Raj stumbled upon the potential of cannabis consumption accessories. Recognizing the margin arbitrage opportunity, he shipped $10,000 worth of consumption accessories to New Delhi and sold everything overnight. After replicating this success a few more times, Raj decided to open a store. This marked the beginning of High Tide's story.
In 2009, Raj opened Smokers’ Corner with an initial investment of less than $50,000 and grew it into a multimillion-dollar empire. At that time, there were only two or three competitors with unappealing stores. Raj believed that by creating a differentiated store in a smart location, he could easily capture market share, and he was right. By leveraging his established roots in Indonesia, Thailand, China, and India, he was able to not only provide a better customer experience but also offer cheaper products.
Cannabis legalization in Canada 🇨🇦
Always looking to stay ahead, Raj seized the opportunity when the Prime Minister of Canada announced that recreational cannabis would soon be legalized. With an existing customer base of cannabis users, it made perfect sense for Raj to expand into selling cannabis itself. He realized that if he only sold accessories, he would eventually lose customers to shops that offered both cannabis and accessories.
After nine years of focusing on consumption accessories and accumulating nearly $10 million in retained earnings, Raj raised $88.5 million for the first time in 2018 and ventured into the equity markets, marking the beginning of High Tide's journey as a publicly traded company. With easier access to capital when compared to its peers, High Tide expanded its footprint across Canada, highlighted by the significant acquisition of its competitor Meta in 2020, which increased the number of stores from 37 to 67.
Around the same time, $HITI began acquiring e-commerce businesses selling accessories and CBD-related products with higher margin profiles, a pivotal decision for the company. From acquiring several brands in the U.S., such as Smoke Cartel, FABCBD, Daily High Club, DankStop, and NuLeaf Holdings, to later acquiring BlessedCBD in the UK, High Tide leveraged its market power to enhance margins and diversify its revenue streams. The company continued to grow both organically and through acquisitions, expanding the number of brick-and-mortar stores across Canada.
The strategy shift that made everything change 👀
In the summer of 2021, $HITI was accepted for listing on the Nasdaq, marking a significant milestone. Later that year, a transformative decision was made: High Tide launched a discount club model for its retail stores in October 2021. With consolidated margins higher than those of any competitor due to the previously mentioned CBD-related acquisitions, High Tide could offer cannabis at remarkably low prices, attracting loyal members and rapidly gaining market share. Although this initially involved selling cannabis at a loss, the move proved to be incredibly successful. High Tide's market share increased from less than 4% to over 10% in less than three years, despite representing less than 5% of the total cannabis retail store count. Today, the discount model program has more than 1.4 million members and continues to grow each quarter.
Being the first-of-its-kind discount model was the key differentiating factor that propelled High Tide to become the leading cannabis retailer in Canada. No competitor could match their prices, and Raj targeted cannabis users who consumed regularly and were highly price-sensitive. When I first started investing in High Tide, one of its closest competitors was Fire & Flower Holdings, which ultimately went bankrupt following this price war. This strategy also significantly diminished the illicit market, further strengthening High Tide’s market share.
After capturing market share, it was time to turn profitable 💰
While Raj sacrificed margins to achieve this, economies of scale and various initiatives aimed at improving margins allowed $HITI to become positive free cash flow again in 2023, as well as positive net income in the most recent quarterly results, with a consolidated leadership position stronger than ever. Examples of these margin improvement initiatives include the acquisition of Fastendr™ Retail Kiosk and Smart Locker Technology, which, after installation in most stores, led to a decrease in General and Administrative costs. Additionally, the company began releasing white-label products with higher gross margins and introduced the new loyalty program ELITE, offering even higher discounts for a small monthly fee. This paid membership grew by 226% YoY last quarter, reaching its fastest pace ever.
Overall, High Tide took a calculated risk to become the leader in the country, and it proved to be incredibly successful. This success was only possible due to the CEO's extensive experience in the sector and deep understanding of the cannabis consumer, surpassing that of any other management team.
Thanks for reading! I really hope you enjoyed it.
While $HITI has been gradually solidifying its position in the Canadian market, the best is yet to come.
High Tide will continue to grow its market share domestically and expand into Germany and the U.S. as soon as possible.
Stay tuned.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Today brought several key updates on $NBIS that further reinforced my high conviction in the company.
Here’s a breakdown of the most important takeaways: 🧵👇🏻
1. First, it’s worth noting that the source is a Seeking Alpha article titled “Nebius: Minutes Of Our Call With The Company.”
I highly recommend reading the full piece.
The author had a brief call with $NBIS' IR team and shared a summary of the conversation.
2. $NBIS has more demand than it can supply.
“Our customer base is in strong demand. Those customers are utilizing our full stack, and we are providing them with significant additional value beyond the GPU.
In March, we were fully sold out, and we got additional GPUs and are selling the additional capacity well.
We feel very good about the demand for our services.”
So no, the market is not saturated by any means — and $NBIS has key differentiators that make it a top choice for customers.
Until last week, my portfolio consisted only of founder-led stocks, but I finally made an exception by opening a position in $DLO.
Here’s a thread breaking down my investment thesis and why I believe its CEO deserves my trust: 👇🏻🧵
1. Origins
$DLO was founded as a response to a pressing issue in Latin America: the difficulty of making online payments. The company’s origins trace back to Uruguay, where Sebastián Kanovich, one of the key founders, first encountered the problem firsthand. As a young economist with no prior background in technology, Sebastián stumbled into the fintech world by chance when he realized that making international online purchases was nearly impossible for consumers in his home country. His personal frustration — specifically, being unable to buy an NBA League Pass or shop online without borrowing a credit card — led him to recognize a larger systemic issue.
He joined forces with two partners who had already begun assembling an initial team to address these payment challenges. At the time, he was working at Santander Bank but was drawn to the opportunity to build something innovative. The founding team’s first venture into payments was a small-scale operation, focusing on a single solution for one customer. They initially operated with a kiosk model, solving local payment issues in Uruguay before expanding their scope.
The company’s first major breakthrough came with Brazil’s Boleto system, a widely used cash-based payment method. Traditionally, Brazilian consumers would generate a Boleto — a type of payment slip — and physically pay it at a bank or kiosk. $DLO developed a solution that digitized this process, allowing users to issue Boletos at checkout and complete transactions seamlessly. While the team initially believed they had solved a major problem, they soon realized that payment challenges extended far beyond Brazil and involved a wide array of localized payment methods across Latin America, Africa, and Asia.
$DLO's growth trajectory accelerated as global companies began seeking ways to expand into emerging markets. Initially, large U.S. firms like Facebook and Google were hesitant to invest in Latin American payment solutions, focusing instead on European expansion. However, as emerging markets gained importance in global business strategies, interest in $DLO's services grew. The company transitioned from offering just a single payment method to aggregating over 900 different payment solutions across various regions, all accessible through a single API. This comprehensive approach significantly increased $DLO's value proposition.
A pivotal moment came when GoDaddy became $DLO's first major U.S. client. Initially, $DLO attempted a direct-to-consumer (B2C) model, launching a prepaid card under its own brand. However, GoDaddy’s feedback was clear: customers didn’t care about the brand, they cared about seamless payment solutions. This insight pushed $DLO to pivot towards a B2B model, positioning itself as an infrastructure provider rather than a consumer-facing brand. This shift proved to be a game-changer, enabling the company to secure more enterprise clients and scale its operations globally.
2. Current Operations
$DLO's mission is to enable global merchants to connect seamlessly with billions of emerging market users.
The company provides payment solutions for some of the world’s largest enterprises, including Amazon, Uber, Microsoft, Shopify, Google, Spotify, Tencent, Shein, Salesforce, Nike, Booking, and Shopee, among others. By simplifying the complex payment landscapes of emerging markets, $DLO helps businesses expand into high-growth regions without the typical friction associated with cross-border transactions.
How Dlocal Makes Money
$DLO operates a high-margin, scalable business model built around direct integrations with global merchants. Once onboarded, companies can access $DLO's full suite of payment solutions through a single API and contract, eliminating the need for multiple legacy providers. This direct connection serves as both a competitive advantage and a barrier to entry, making incremental transaction volume highly accretive (I'll address these topics later).
The company generates revenue primarily through transaction fees on pay-in (consumer payments) and pay-out (merchant disbursements) services. These fees can be a percentage of the transaction value, a fixed fee per transaction, or a spread on foreign exchange conversions. $DLO also charges for services like chargeback management and installment payments, which further contribute to its revenue stream.
Revenue Breakdown:
• Processing fees – Charged as a percentage of transaction value or a fixed fee per approved transaction.
• Installment fees – Fees applied to transactions where consumers opt for installment payments.
• Foreign exchange fees – A spread on currency conversions in cross-border transactions.
• Other transactional fees – Includes chargeback and refund fees, as well as ancillary services.
•Other revenues – Setup fees, maintenance fees, and other small service charges.
Cost Structure
$DLO's cost of services primarily consists of fees paid to financial institutions, such as banks and local acquirers, for processing payments. These costs vary depending on settlement periods and payment methods. Additional expenses include infrastructure costs, salaries of operational staff, and amortization of internally developed software.
One of the key risks in $DLO's model is foreign exchange exposure, as transactions often involve multiple currencies. However, the company mitigates this risk through hedging strategies, using derivatives to offset currency fluctuations.
Apart from COGS, $DLO's main costs fall into two categories:
• Technology & Development: This includes salaries and wages for tech teams, infrastructure costs, information security expenses, software licenses, and other technology-related investments.
• SG&A: These are the regular operating expenses required to run the business.
Since the arrival of the new CEO, $DLO has increased spending on technology infrastructure and back-end capabilities to enhance its solutions and maintain its position as an innovator with a long-term mindset. While these investments initially pressured margins, they are strategically important for long-term value creation — I’ll revisit this when discussing the company’s future margin recovery.
Overall, $DLO's business model is highly scalable, with minimal incremental costs, positioning it to unlock significant operating leverage as it continues its impressive growth trajectory.
Key Performance Indicator: TPV Growth
Total Payment Volume (TPV) is probably the most important metric to gauge $DLO's relevance and execution over the past few years.
From 2016 to 2023, the company grew from just $136M in TPV to $17.7B — a CAGR of over 100%. 🤯
In 2024, growth is expected to exceed 40%, highlighting $DLO's continued expansion in emerging markets and its ability to attract major global enterprises seeking seamless payment solutions.
With a massive untapped market ahead, the company still has significant room to scale.
Founder-led companies have historically outperformed the market by a wide margin — but choosing wisely is crucial.
Here are 10 interesting companies where the founder remains both the CEO and the largest shareholder: 👇🏻🧵
1) $NBIS
• Emerging leader in AI infrastructure, providing a full-stack AI cloud platform, high-performance computing, and advanced data center solutions
• Its story begins within Yandex, but it’s now fully independent, with no ties to Russia — founder and executives relocated and changed nationalities to avoid sanctions
• Positioned to benefit from the skyrocketing demand for AI computing power, offering cost-effective and energy-efficient solutions
• Strong competitive edge in cost efficiency, with total GPU costs up to 25% lower than industry averages due to vertical integration and strategic partnerships
• Industry-leading energy efficiency, with best-in-class Power Usage Effectiveness (PUE) of ~1.13
• Strategic partnership with NVIDIA, which recently invested in $NBIS — will be the first provider in Europe to offer NVIDIA’s new Blackwell GPUs in 2025
• Expanding aggressively, with plans to triple its Finland data center capacity and launch new facilities across Europe and the U.S., targeting 240,000 GPUs by 2027+
• Surging Annual Recurring Revenue (ARR), growing from $21M in 2023 to an estimated $170M–$190M in 2024, with projections of $750M–$1B ARR by 2025
• Strong balance sheet with over $2B in cash and no debt, but likely to raise more capital to accelerate expansion
• Several non-core divisions, including Avride (autonomous driving tech with Uber partnerships), Toloka (AI data solutions), and TripleTen (edtech), adding optionality and potential future value
• Trading at an attractive valuation compared to peers, with 7–8x forward EV/ARR despite expected 4–5x YoY growth in 2025 and 100%+ growth in 2026
• Potential for over 30% CAGR over the next few years IMO, with significant upside as institutional investors recognize its growth potential
2) $HIMS
• Cash-pay model that bypasses the need for insurance
• Provides high-quality, personalized, and affordable healthcare treatments (involved in the whole process)
• Positioned to benefit from many secular trends in the huge telehealth market
• Optionality to launch new categories and easily expand into new markets (several potential catalysts)
• Customer-centric approach that delivers a better experience than its peers
• Innovation stack combined with remarkable execution positions it for continued success
• Many years of customer data make some of its competitive advantages harder to replicate, particularly the personalization of dosages to improve outcomes and reduce side effects
• 2M+ subscribers growing 40%+ YoY
• Percentage of personalized subscribers increasing at an incredibly fast rate
• Improving retention rates, a critical factor in this sector
• Highly efficient distribution network, with thousands of affiliated pharmacies
• Investing in infrastructure to verticalize its supply chain
• Capex-light business model with impressive margins (75%+ gross margins, 15%+ FCF)
• Consistently surpassed analysts' estimates since inception
• Growing revenues by 65%+ this year, and likely to compound >20%/year over the next 5 years, with further operating leverage expected
• No debt and an increasing cash pile, even while executing buybacks and reinvesting in growth and optimization
3) $HITI
• The company was founded in 2009 and initially focused on selling cannabis consumption accessories
• After Canada announced the upcoming legalization of recreational cannabis, $HITI leveraged its existing customer base to expand into selling the plant itself
• Around 2018-2020, the company entered the equity markets and used its easier access to capital to expand its store footprint aggressively
• During the same period, $HITI acquired several e-commerce brands selling CBD products and consumption accessories, which had much higher margins than its core business
• In 2021, $HITI launched a discount club model for its retail stores — with consolidated margins higher than any competitor due to its acquisitions, $HITI could offer cannabis at remarkably low prices, attracting loyal members and rapidly gaining market share
• Its market share grew from less than 5% to over 11% in three years, and is expected to reach 15% over the next years as dozens of stores, including large corporations, are going bankrupt every month
• While the company sacrificed margins to win the price war, economies of scale and other initiatives enabled it to become both FCF and net income positive, with margins trending up
• After the success of its free discount model, which gathered over 1.5M members in under three years, $HITI launched ELITE, a paid membership with even better offers (members are growing 160%+ YoY)
• There's still significant market potential to capture in Canada, as well as international catalysts like the expansion into the U.S. and Germany
• While the previously mentioned e-commerce brands were important to sustain the initial launch of $HITI's discount model, they have recently become a hurdle — to deal with that, the company announced a global paid membership which aims to consolidate the fragmented CBD market
• White-label products will play a crucial role in improving $HITI's margins over time, with the company aiming to increase their share from 2.5-3% of SKUs to 20-25% of all store offerings in the long term
• The average $HITI store generates ~$2.6M in annual revenue, compared to $1.0M for peers, not only due to its proven business model but also because the company focuses on selecting the best locations
• $HITI recently acquired Purecan, a Germany wholesaler of medical cannabis. This move is highly strategic given that most medical cannabis in Germany is imported from Canada, and as the largest cannabis retailer in Canada, $HITI has established relationships with every major Licensed Producer (LP) — providing a significant competitive advantage
• This deal represents a transformational opportunity for $HITI to expand its TAM and experience significant operating leverage
Last week, $HITI released its Q4 2024 earnings report.
As a longtime shareholder, I’ve been closely following the company for years.
Here’s a breakdown of everything: 🧵👇🏻
1. Let’s start with the Financial Results.
Record revenue of $138.3M, exceeding consensus estimates of $135M. 🟢
Signs of revenue acceleration, with double-digit growth expected in 2025. The core business grew 12% YoY, but overall growth was slightly offset by underperformance in e-commerce.
Despite a $35.2M revenue increase, total expenses declined by $5.9M, demonstrating disciplined cost management.
FCF increased from $7M to $22M YoY (+217%), highlighting improved operational efficiency.
Adjusted EBITDA rose 25% YoY to $38.3M, with margin expansion from 6.3% to 7.3%.
Achieved Net Income profitability (excluding non-cash impairments) for the first time: $1.2M vs. a ($6.7M) loss YoY.
Same-store sales (SSS) increased 0.4% YoY and 3% QoQ, outperforming the broader cannabis retail market, which declined 1% YoY. I was expecting SSS to show slightly better growth, but it’s still a solid performance given the overall market conditions.
Gross margins remained stable YoY at 26% (down from 27% QoQ) – The company is avoiding price increases to allow weaker competitors to exit the market, setting up for future margin expansion.
“More and more competitors are leaving the race, big chains are struggling, middle size chains are struggling, independents are struggling. So as more competitors get out of the race, there's not going to be a lot of competitors remaining to be waging a price war with us. And at that point, we have a tremendous opportunity to increase gross margins in our core Canadian cannabis business.”
$HITI ended the fiscal year with a record cash balance of $47.3M and no debt maturities until September 2027. Total debt stands at $27M, with only $12M maturing in 2027.
All in all, $HITI delivered a strong quarter. As industry consolidation progresses, the company is well-positioned to enhance margins and drive sustained long-term growth. It’s important to note that the overall market has been struggling due to the resurgence of the illicit market, but management has been highly competent in navigating these short-term headwinds.
2. Footprint Expansion: Store Openings & Future Outlook
Accelerated and Self-Funded Store Growth:
• 29 new stores opened in 2024 (vs. 13 in 2023), more than doubling the prior year’s expansion and hitting the high end of guidance (20-30 stores). The company now owns 191 stores across five provinces.
• Growth was primarily organic, with only one store acquired — demonstrating disciplined expansion.
• Notably, all new stores were funded entirely through internal FCF, a rare achievement in the sector.
• Cost per store opening: ~$260K in build-out costs + $100K–$150K in working capital.
2025 Expansion Plans:
• Targeting another 20–30 new stores, all organically developed and funded by internal FCF.
• Management remains highly selective on M&A, despite ongoing inbound interest from struggling small chains and independent operators. Raj Grover has emphasized acquiring only highly strategic locations at deeply distressed valuations — evidenced by the last store acquisition in June 2024 at just 1.5x annualized Adj. EBITDA.
New store openings require upfront CapEx, working capital, and employee ramp-up, temporarily weighing on consolidated results. The 217% YoY FCF growth becomes even more impressive when we consider the ramp-up in store openings.
$HITI continues to lead the sector with best-in-class revenue per store:
• $2.6M per store vs. $1.2M industry average.
• In Ontario, the company’s key growth market, the gap is even wider: $3.5M per store vs. $1.1M from peers.
• Annualized retail sales per square foot across the Canna Cabana store network reached $1,699 in the fourth fiscal quarter of 2024, up 2% QoQ. This exceeded best-in-class retailers such as Walmart, Target, and Canadian Tire.
Alignment between managers and shareholders is one of the most important drivers of long-term success.
Here are 8 stocks from companies where the Founder & CEO holds a 20%+ stake: 👇🏻🧵
1) $TEM
The Founder & CEO, Eric Lefkofsky, owns 24.7% of the company.
Everyone is talking about it after Nancy Pelosi purchased $50k–$100k worth of call options set to expire in January 2026. Following a rally of over 30% because of this, I’ve decided not to start a position for now. However, it’s definitely an intriguing company that I’m keeping on my radar.
• It’s essentially a precision medicine company leveraging AI to analyze clinical and molecular data, enabling personalized treatment decisions, advancing drug discovery, and facilitating earlier disease diagnosis
• Initially, the company focused solely on oncology patients, but it soon recognized the immense potential of expanding into other diseases
• They’ve built the world’s largest library of clinical and molecular data, and now every major pharmaceutical company wants to collaborate with them
• The key advantage lies in the comprehensiveness of their datasets and AI tools, which enable deeper insights and more actionable results
• More than 50% of oncologists in the U.S. are using $TEM, creating a strong network effect
• The post-IPO lockup period recently expired, which is why the stock is down ~50% in the last month or so (potential opportunity)
• The recently announced acquisition of Ambry Genetics will accelerate its path to profitability, with the combination of both businesses already being EBITDA and cash flow positive (according to $TEM's CEO in the last earnings call) — this should be a strong catalyst
• As $NVDA's CEO said, I believe the next revolution brought by AI will be in biotech/healthcare, so I'm expecting this sector to get hotter in the foreseeable future
• In 2024, $TEM's Data Licensing revenue had a NRR of ~140%
• 19 of the 20 largest public pharmaceutical companies in the world are collaborating with $TEM
• The AI healthcare market is projected to grow from ~$21B in 2024 to close to $150B in 2029, a CAGR of over 48% — $TEM is in a unique position to benefit from this
• Both Google and Novo Nordisk are shareholders of the company
2) $ELIX.L
The Founder & CEO, Stephen Newton, owns 24.1% of the company.
• Elixirr provides tailored consulting services across industries, specializing in innovation, strategy, and digital transformation (including AI and data-related services)
• It consistently delivers double-digit revenue growth with very solid margins (H1 29% Adj. EBITDA and 13% FCF)
• Impressive selection of clients, including Bank of America, LVMH, Tesla, Bloomberg, Diageo, and many others
• Elixirr has been named on the World’s Best Management Consulting Firms 2024 list by Forbes
• It has a solid cash balance with literally no debt
• Elixirr’s M&A team screened a further 700+ targets in H1 2024, with several potential acquisition opportunities currently in advanced stages
• Expected to grow revenue by >25% this year
• A valid risk to point out is the company’s customer concentration, with ~49% of revenue coming from the top 10 customers
I have to admit, this company only recently caught my attention through a screener, so I still need to conduct more research on it.
3) $NU
The Founder & CEO, David Velez, owns ~20% of the company.
• As a neobank without physical branches, $NU leverages technology to offer affordable and accessible financial services, expanding banking access in Latin America
• Over 100M active customers with a remarkable track record of exceeding expectations
• $NU's cohort curves demonstrate that the company is not only increasing its active customers but also making these customers more valuable over time
• $NU excels in the four cost pillars of retail financial services — cost to acquire, cost to serve, cost of risk, and cost of funding — giving it competitive advantages over rivals
• Thanks to its low-cost structure and rapidly growing customer base, $NU has shown strong operating leverage
• While most of $NU's revenue comes from Brazil, its business in Mexico is showing incredible potential
Nancy Pelosi just bought $50k-$100k in call options for $TEM.
It’s unusual for her to invest in small-cap stocks, so now everyone is wondering what’s so special about it...
Luckily, I was already preparing a thread about the company.
Here's an extensive summary of $TEM's investment thesis: 👇🏻🧵
1. Introduction to $TEM
Tempus AI, or $TEM, is a cutting-edge precision medicine company founded in 2015 by Eric Lefkofsky. The inspiration for Tempus arose from Lefkofsky’s personal life — his wife’s battle with breast cancer revealed how limited the role of technology was in shaping her care. Determined to change this, Lefkofsky set out to integrate advanced technology into healthcare, addressing a critical gap in the industry.
At its core, $TEM leverages AI to analyze vast amounts of clinical, imaging and molecular data. Its goal is ambitious yet clear: to revolutionize healthcare by enabling personalized treatment decisions, advancing drug discovery, and facilitating earlier and more accurate disease diagnoses.
$TEM initially focused only on oncology, enabling doctors to deliver tailored treatments for cancer patients. This “intelligent diagnostics” model proved so effective that the company expanded its efforts into other critical areas, such as neuropsychology and cardiology.
Today, $TEM's technology empowers thousands of physicians and life science companies, making a tangible difference in patients' lives.
2. The Booming Market for AI in Healthcare
The global AI in healthcare market is experiencing unprecedented growth, projected to expand from $15B in 2024 to a staggering $164B by 2030, representing a CAGR of 49.1%. 🤯
This explosive growth is driven by several factors, including:
• Increased Investments: Significant public and private sector funding is accelerating the adoption of AI technologies in healthcare.
• Rapid AI Proliferation: The integration of AI into healthcare systems is transforming diagnostics, treatment planning, and patient outcomes.
• Focus on Human-Aware AI Systems: Advances in AI technology are enabling more personalized and human-centered solutions, which are crucial in the healthcare domain.
$TEM is uniquely positioned to capitalize on some of these trends.
With its AI-powered precision medicine platform, $TEM is not only a pioneer in embedding AI into healthcare workflows but also a leader in driving real-world impact.